We are live on ! Find out more

Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
ADAG
576
Adagene
ADAG
$254M
$254M $3.85 5.77%
INFU icon
577
InfuSystem Holdings
INFU
$253M
$253M $12.56 1.95%
SRZN icon
578
Surrozen
SRZN
$250M
$250M $21.53 2.14%
OBIO icon
579
Orchestra BioMed
OBIO
$250M
$250M $4.17 2.34%
NAGE
580
Niagen Bioscience
NAGE
$248M
$248M $3.12 10.1%
MGNX icon
581
MacroGenics
MGNX
$248M
$248M $3.90 0%
RNAC icon
582
Cartesian Therapeutics
RNAC
$242M
$242M $8.25 2.36%
BDSX icon
583
Biodesix
BDSX
$238M
$238M $23 1.05%
ACIU icon
584
AC Immune
ACIU
$238M
$238M $2.34 3.08%
FOCL
585
EDAP TMS S.A.
FOCL
$236M
$236M $6.30 0.63%
ACH
586
Accendra Health
ACH
$236M
$236M $3.08 4.76%
CAPR icon
587
Capricor Therapeutics
CAPR
$231M
$231M $3.99 4.32%
SPOK icon
588
Spok Holdings
SPOK
$231M
$231M $11.02 1.69%
TARA icon
589
Protara Therapeutics
TARA
$227M
$227M $4.04 0.75%
CHRS icon
590
Coherus Oncology
CHRS
$227M
$227M $1.47 0.68%
UTMD icon
591
Utah Medical Products
UTMD
$225M
$225M $70.53 2.45%
SIGA icon
592
SIGA Technologies
SIGA
$224M
$224M $3.13 3.4%
PDEX icon
593
Pro-Dex
PDEX
$218M
$218M $68.26 0.26%
MSLE
594
Satellos Bioscience
MSLE
$217M
$217M $10.41 3.79%
CGEN icon
595
Compugen
CGEN
$217M
$217M $2.29 3.78%
AMWL icon
596
American Well
AMWL
$216M
$216M $12.94 24.2%
CAMP icon
597
CAMP4 Therapeutics
CAMP
$214M
$214M $4.12 0.96%
EMBC icon
598
Embecta
EMBC
$214M
$214M $3.60 5.76%
GLSI icon
599
Greenwich LifeSciences
GLSI
$210M
$210M $14.30 0.35%
WHWK
600
Whitehawk Therapeutics
WHWK
$208M
$208M $4.21 1.69%
22 23
24
25 26

Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 1,068 Healthcare sector stocks tracked by Wall St. Rank, worth a combined $9.03T.

The largest by market cap are Eli Lilly (LLY) at $1.03T, Johnson & Johnson (JNJ) at $620B and AbbVie (ABBV) at $439B.

Among institutional investors, Waters Corp (WAT) drew the most net new fund positions in Q1 2026: 461 funds opened new positions, taking total fund holders up 365 (45%) quarter-over-quarter.

  • Combined market cap: $9.03T across 1,068 stocks.
  • Largest constituent: Eli Lilly (LLY), $1.03T market cap.
  • Most net new fund positions in Q1 2026: Waters Corp (WAT), +365 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.